» Articles » PMID: 2492381

Type 1 Plasminogen Activator Inhibitor

Overview
Date 1989 Jan 1
PMID 2492381
Citations 49
Authors
Affiliations
Soon will be listed here.
Citing Articles

The 4G/5G Polymorphism of Plasminogen Activator Inhibitor Type 1 is a Predictor of Moderate-to-Severe Thyroid Eye Disease.

Katko M, Galgoczi E, Erdei A, Gazdag A, Berta E, Bodor M J Inflamm Res. 2021; 14:1883-1890.

PMID: 34012286 PMC: 8126970. DOI: 10.2147/JIR.S307046.


The Predictive Role of Tenascin-C and Cellular Communication Network Factor 3 (CCN3) in Post Hepatectomy Liver Failure in a Rat Model and 50 Patients Following Partial Hepatectomy.

Li H, Ge X, Pan K, Sui M, Cai H, Cui C Med Sci Monit. 2019; 25:6755-6766.

PMID: 31494663 PMC: 6752097. DOI: 10.12659/MSM.917331.


Plasminogen activator inhibitor-1: a risk factor for deep vein thrombosis after total hip arthroplasty.

Tang J, Zhu W, Mei X, Zhang Z J Orthop Surg Res. 2018; 13(1):8.

PMID: 29321050 PMC: 5763522. DOI: 10.1186/s13018-018-0716-2.


Inhibition of PAI-1 Activity by Toddalolactone as a Mechanism for Promoting Blood Circulation and Removing Stasis by Chinese Herb var. .

Yu B, Zhang G, Jin L, Zhang B, Yan D, Yang H Front Pharmacol. 2017; 8:489.

PMID: 28785222 PMC: 5519579. DOI: 10.3389/fphar.2017.00489.


Plasminogen activator inhibitor-1 is elevated in patients with COPD independent of metabolic and cardiovascular function.

Waschki B, Watz H, Holz O, Magnussen H, Olejnicka B, Welte T Int J Chron Obstruct Pulmon Dis. 2017; 12:981-987.

PMID: 28356730 PMC: 5367764. DOI: 10.2147/COPD.S128689.